Dupilumab for occupational irritant hand dermatitis in a nonatopic individual: A case report
Gefei Alex Zhu, Golara Honari, Justin Ko, Albert S. Chiou, Jennifer K. Chen
Abstract
Dupilumab is a monoclonal antibody targeting interleukin-4 and interleukin-13 for the treatment of moderate-to-severe atopic dermatitis.1 We report a case of occupational irritant hand dermatitis in a nonatopic individual that improved on dupilumab.
Topics & Concepts
DupilumabMedicineAtopic dermatitisDermatologyIrritant contact dermatitisImmunologyHand dermatitisAllergyContact dermatitisDermatology and Skin DiseasesContact Dermatitis and AllergiesAllergic Rhinitis and Sensitization